Concourse Financial Group Securities, Inc. Boston Scientific Corp Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 7,040 shares of BSX stock, worth $633,600. This represents 0.04% of its overall portfolio holdings.

Number of Shares

7,040

Previous 7,717 8.77%

Holding current value

$633,600

Previous $594,000 0.84%

% of portfolio

0.04%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$72.96 - $84.0 $49,393 - $56,868	-677 Reduced 8.77%	7,040 $589,000
Q2 2024 Jul 23, 2024	SELL	$67.33 - $77.71 $8,348 - $9,636	-124 Reduced 1.58%	7,717 $594,000
Q1 2024 Apr 30, 2024	BUY	$57.6 - $68.62 $32,832 - $39,113	570 Added 7.84%	7,841 $537,000
Q4 2023 Feb 07, 2024	SELL	$48.64 - $57.81 $4,961 - $5,896	-102 Reduced 1.38%	7,271 $420,000
Q3 2023 Oct 25, 2023	SELL	$50.19 - $54.68 $21,230 - $23,129	-423 Reduced 5.43%	7,373 $389,000
Q2 2023 Aug 10, 2023	BUY	$49.72 - $54.64 $142,050 - $156,106	2,857 Added 57.85%	7,796 $421,000
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $86,392 - $95,857	1,916 Added 63.38%	4,939 $247,000
Q4 2022 Jan 30, 2023	SELL	$39.56 - $47.22 $10,325 - $12,324	-261 Reduced 7.95%	3,023 $0
Q3 2022 Nov 15, 2022	SELL	$36.71 - $109.66 $11,159 - $33,336	-304 Reduced 8.47%	3,284 $127,000
Q2 2022 Aug 09, 2022	SELL	$35.24 - $47.1 $18,113 - $24,209	-514 Reduced 12.53%	3,588 $134,000
Q1 2022 May 09, 2022	SELL	$40.9 - $45.1 $30,552 - $33,689	-747 Reduced 15.41%	4,102 $182,000
Q4 2021 Feb 07, 2022	BUY	$38.07 - $44.87 $4,301 - $5,070	113 Added 2.39%	4,849 $206,000
Q3 2021 Nov 09, 2021	BUY	$41.23 - $45.88 $49,352 - $54,918	1,197 Added 33.82%	4,736 $205,000
Q2 2021 Aug 13, 2021	BUY	$38.58 - $44.24 $1,350 - $1,548	35 Added 1.0%	3,539 $151,000
Q1 2021 May 13, 2021	SELL	$35.27 - $39.67 $58,618 - $65,931	-1,662 Reduced 32.17%	3,504 $135,000
Q4 2020 Feb 02, 2021	SELL	$33.15 - $41.97 $328,814 - $416,300	-9,919 Reduced 65.75%	5,166 $186,000
Q3 2020 Nov 13, 2020	BUY	$34.44 - $42.23 $46,184 - $56,630	1,341 Added 9.76%	15,085 $576,000
Q2 2020 Aug 13, 2020	BUY	$30.19 - $39.11 $49,692 - $64,375	1,646 Added 13.61%	13,744 $483,000
Q1 2020 May 13, 2020	SELL	$25.83 - $45.71 $39,649 - $70,164	-1,535 Reduced 11.26%	12,098 $395,000
Q4 2019 Feb 14, 2020	BUY	$37.87 - $45.37 $332,687 - $398,575	8,785 Added 181.21%	13,633 $616,000
Q3 2019 Nov 13, 2019	BUY	$40.31 - $43.45 $21,283 - $22,941	528 Added 12.22%	4,848 $197,000
Q2 2019 Aug 13, 2019	BUY	$34.91 - $42.98 $34,875 - $42,937	999 Added 30.08%	4,320 $186,000
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $76,087 - $94,214	-2,312 Reduced 41.04%	3,321 $127,000
Q4 2018 Feb 14, 2019	BUY	$31.73 - $39.04 $152,050 - $187,079	4,792 Added 569.8%	5,633 $199,000
Q3 2018 Nov 13, 2018	BUY	$32.83 - $38.63 $27,610 - $32,487	841 New	841 $32,000

Others Institutions Holding BSX

# of Institutions

1,539

Shares Held

1.19B

Call Options Held

6.79M

Put Options Held

10.1M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $129B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Boston Scientific Corp Transaction History